Clinical and angiographic follow up results
| Number | |
|---|---|
| Patients | |
| Six months of clinical follow up obtained (%) | 41/41 (100) |
| Mean clinical follow up (months) (mean (SD)) | 8.9 (3.6) |
| Death (%) | 1/41 (2) |
| Non-Q wave myocardial infarction (%) | 1/41 (2) |
| Subacute stent thrombosis at one month (%) | 0/41 (0) |
| Recurrence of angina symptoms (%) | 10/41 (24) |
| Repeat PTCA for restenosis (%) | 9/41 (22) |
| CABG (%) | 1/41 (2) |
| Lesions | |
| Angiographic follow up obtained (%) | 53/63 (84) |
| Time to follow up (months) (mean (SD)) | 5.4 (1.7) |
| Target lesion revascularisation (%) | 17/63 (27) |
| Repeat PTCA (%) | 16/63 (25) |
| CABG (%) | 1/63 (2) |
| ⩾ 50% restenosis treated medically (%) | 2/63 (3) |
| ⩾ 50% diameter restenosis (%)4-150 | 19/53 (36) |
| Diffuse (⩾ 10 mm length) (%) | 10/19 (53) |
| Focal (< 10 mm length) (%) | 9/19 (47) |
| Patients | |
| Patients without angiographic follow up (%) | 8/41 (20) |
| Died (%) | 1/8 (13) |
| CCS class I + positive stress test (%) | 1/8 (13) |
| Asymptomatic + negative stress test (%) | 6/8 (74) |
↵4-150 Per lesion with angiographic follow up.
CABG, coronary artery bypass graft; CCS, Canadian Cardiovascular Society; PTCA, percutaneous transluminal coronary angioplasty.